IBS-trained therapists are hard to find. That’s why we developed the first prescription-only, FDA-cleared mobile app that delivers cognitive behavioral therapy for IBS. Over 60% of patients treated with Mahana IBS in a clinical trial reported a clinically meaningful improvement in IBS symptom severity.
Sign up and you’ll receive:
Once your NPI number is verified (up to 1 business day), you’ll receive an email with your complementary prescriptions, Patient Discussion Guide and Best Practices Guide.
Sign up and you'll receive:
The efficacy and safety of Mahana IBS was demonstrated in the ACTIB trial of 558 adult patients with refractory IBS. Mahana helped nearly 2 in 3 people in a clinical trial.1,2
We're working with leaders in gastroenterology to ensure patient and provider have the tools they need for IBS treatment.
Hazel Everitt, Ph.D, FRCGP
University of Southampton, GP & Professor of Primary Care Research
Emeran Mayer, M.D.
UCLA, Director, G. Oppenheimer Center for Neurobiology of Stress and Resilience (CNSR)
Jasmine Zia, M.D.
Swedish Medical Center, Gastroenterologist
Rona Moss-Morris, Ph.D
King's College London, Head of Psychology Department, Institute of Psychiatry, Psychology & Neuroscience
Sign up today and get early access to the first FDA-cleared app for IBS symptom treatment.Get our PDF on How to Prescribe
Mahana’s Cognitive Behavioral Therapy is gut-directed psychotherapy (GDP) that improves IBS symptom severity by targeting the cognitive factors known to drive symptoms. CBT is the most rigorously tested psychological treatment for IBS.
Mahana enables you to empower all IBS patients with a treatment that has no known side effects.
The gut-brain axis is a bidirectional communication system that links intestinal functions with the emotional and cognitive centers of the brain.
Be on the leading-edge with providers who understand the importance of staying on top of the latest treatments like digital therapeutics.
Explaining to patients the benefits of using Mahana is fast and simple.
Our Patient FAQ sheet helps explain the brain-gut connection and allows patients to learn about the benefits of digital IBS therapy with Mahana IBS.
Mahana’s CBT model helps patients develop skills in 10 key areas over the course of 3 months to reduce severity of symptoms.
Good therapists with IBS specific training are hard to find, and IBS case workloads can take up significant clinical time.
Give patients the only FDA-cleared digital therapy shown in clinical trials to reduce symptom severity.
Patients have more information at their fingertips than ever before. That’s why it’s imperative for physicians to anticipate and understand consumer health trends.
Mahana IBS is the first and only FDA cleared digital IBS treatment. With Mahana IBS, physicians can be confident they are prescribing an efficacious and safe digital health treatment
In 2021, the number of people using digital therapeutics is expected to reach 44 million worldwide. Almost double the number of users in 2020.4